VWA
GILD icon

VSM Wealth Advisory’s Gilead Sciences GILD Stock Holding History

VSM Wealth Advisory’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$95K Hold
752
– – 0.03% 165
2026
Q1 		$105K Hold
752
– – 0.03% 151
2025
Q4 		$92.3K Hold
752
– – 0.03% 148
2025
Q3 		$83.4K Hold
752
– – 0.03% 153
2025
Q2 		$83.3K Hold
752
– – 0.03% 158
2025
Q1 		$84.2K Hold
752
– – 0.03% 146
2024
Q4 		$69.4K Buy
+752
New +$67.7K 0.02% 166

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

VSM Wealth Advisory's GILD Position: Q2 2026 in Review

VSM Wealth Advisory held its Gilead Sciences (GILD) position steady in Q2 2026 at 752 shares worth $95K. The position accounts for 0.03% of the portfolio, ranked #165.

VSM Wealth Advisory first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $105K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • VSM Wealth Advisory held 752 shares of Gilead Sciences worth $95K as of Q2 2026.
  • VSM Wealth Advisory left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.03% of VSM Wealth Advisory's portfolio in Q2 2026, its #165 holding.
  • VSM Wealth Advisory first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • VSM Wealth Advisory's Gilead Sciences position peaked at $105K in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on VSM Wealth Advisory's 13F filing for Q2 2026, filed 23 Jul 2026.